Mads Hald Andersen at National Center for Cancer Immune Therapy, CCIT-DK - Research Interests, Publications & Academic Profile

Mads Hald Andersen

Professor, dr.techn., Director

University Name

Denmark

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Indian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Immunology

100%

Cell Biology

40%

Immunomodulation

50%

Tumor Immunology

40%

Regulatory T Cells

40%

Hematopoiesis

30%

Immunotherapy

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles14

Increased myeloid‐derived suppressor cell activation in clonal cytopenia of undetermined significance and low‐risk myelodysplastic syndrome

Article Link

Year:

2024

Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells

Article Link

Year:

2024

TGFβ-specific T cells induced by a TGFβ-derived immune modulatory vaccine both directly and indirectly modulate the phenotype of tumor-associated macrophages and fibroblasts

Article Link

Year:

2024

Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy

Article Link

Year:

2023

of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes

Article Link

Year:

2023

First in man study

Article Link

Year:

2023

Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms

Article Link

Year:

2023

Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma

Article Link

Year:

2023

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Article Link

Year:

2023

Long-term follow-up of anti-PD-1 naïve patients with metastatic melanoma treated with IDO/PD-L1 targeting peptide vaccine and nivolumab

Article Link

Year:

2023

Novel immune modulatory vaccines targeting TGFβ

Article Link

Year:

2023

Novel immunotherapeutic combinations moving forward: the modulation of the immunosuppressive microenvironment

Article Link

Year:

2023

Tumor microenvironment antigens

Article Link

Year:

2023

Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow

Article Link

Year:

2023

Collaborators8

Özcan Met

Københavns Universitet

DENMARK

Bo Porse

Københavns Universitet

DENMARK

Morten Kranker Larsen

DENMARK

Sine Reker Hadrup

Technical University of Denmark

DENMARK

Morten Andersen

Roskilde University

DENMARK

Marco Donia

Copenhagen University Hospital

DENMARK

Inge Marie Svane

Københavns Universitet

DENMARK

Per thor Straten

Københavns Universitet

DENMARK

How do Indian students reach out?

Meet Kite AI